Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida

Edwardsiella piscicida (E. piscicida) is an important opportunistic fish pathogen, and infects various species of cultured fish posing a great challenge to the aquaculture industry globally. To address the frequent emergence of multi-antibiotics resistant E. piscicida and the shortage of effective a...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinfang Lu, Yangbin Shi, Yajing Pan, Hans-Peter Grossart, Luyu Mei, Danli Xie, Wanchun Guan, He Zhang, Yongliang Lou
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Aquaculture Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352513425002169
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849744722712592384
author Jinfang Lu
Yangbin Shi
Yajing Pan
Hans-Peter Grossart
Luyu Mei
Danli Xie
Wanchun Guan
He Zhang
Yongliang Lou
author_facet Jinfang Lu
Yangbin Shi
Yajing Pan
Hans-Peter Grossart
Luyu Mei
Danli Xie
Wanchun Guan
He Zhang
Yongliang Lou
author_sort Jinfang Lu
collection DOAJ
description Edwardsiella piscicida (E. piscicida) is an important opportunistic fish pathogen, and infects various species of cultured fish posing a great challenge to the aquaculture industry globally. To address the frequent emergence of multi-antibiotics resistant E. piscicida and the shortage of effective antimicrobial treatments, this study aimed to develop a novel combination therapy against E. piscicida. The combination of the FDA approved drug auranofin (originally used to treat rheumatoid arthritis) with colistin exerted great bactericidal effects against E. piscicida both in vitro and in vivo. Auranofin disrupted the thioredoxin system, and decreased the minimum inhibitory concentration (MICcolistin) of E. piscicida. Further, auranofin combined with colistin significantly inhibited the growth of E. piscicida isolates, even resulting in cell death. A mechanistic study revealed that the combination remarkably damaged the bacterial membrane increasing its permeability, and it also promoted a decrease of membrane potential, thereby exacerbating oxidative stress and the bactericidal effects of colistin. Importantly, auranofin combined with colistin strongly attenuated the essential bacterial two-component system, lipopolysaccharide modification, motility and virulence pathways. Moreover, the combination of both chemicals also efficiently reduced E. piscicida burden in the gill, intestine and head kidney of infected zebrafish (Danio rerio), and significantly improved their survival rate. Overall, these results suggested that the thioredoxin-mediated redox cascade is a potential target for novel antimicrobials, and that auranofin combined with colistin could be repurposed to effectively combat Edwardsiella infections.
format Article
id doaj-art-b37544e2562c45d9b0ca10a62e18de0b
institution DOAJ
issn 2352-5134
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Aquaculture Reports
spelling doaj-art-b37544e2562c45d9b0ca10a62e18de0b2025-08-20T03:09:51ZengElsevierAquaculture Reports2352-51342025-07-014210283010.1016/j.aqrep.2025.102830Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicidaJinfang Lu0Yangbin Shi1Yajing Pan2Hans-Peter Grossart3Luyu Mei4Danli Xie5Wanchun Guan6He Zhang7Yongliang Lou8Wenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaWenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaWenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaUniversity of Potsdam, Institute of Biochemistry and Biology, Potsdam 14469, Germany; Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB), Stechlin 16775, GermanyWenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaWenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaWenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaZhejiang Provincial Key Laboratory for Subtropical Water Environment and Marine Biological Resources Protection, National and Local Joint Engineering Research Center of Ecological Treatment Technology for Urban Water Pollution, College of Life and Environmental Sciences, Wenzhou University, Wenzhou, Zhejiang 325035, China; Corresponding authors.Wenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Corresponding authors.Edwardsiella piscicida (E. piscicida) is an important opportunistic fish pathogen, and infects various species of cultured fish posing a great challenge to the aquaculture industry globally. To address the frequent emergence of multi-antibiotics resistant E. piscicida and the shortage of effective antimicrobial treatments, this study aimed to develop a novel combination therapy against E. piscicida. The combination of the FDA approved drug auranofin (originally used to treat rheumatoid arthritis) with colistin exerted great bactericidal effects against E. piscicida both in vitro and in vivo. Auranofin disrupted the thioredoxin system, and decreased the minimum inhibitory concentration (MICcolistin) of E. piscicida. Further, auranofin combined with colistin significantly inhibited the growth of E. piscicida isolates, even resulting in cell death. A mechanistic study revealed that the combination remarkably damaged the bacterial membrane increasing its permeability, and it also promoted a decrease of membrane potential, thereby exacerbating oxidative stress and the bactericidal effects of colistin. Importantly, auranofin combined with colistin strongly attenuated the essential bacterial two-component system, lipopolysaccharide modification, motility and virulence pathways. Moreover, the combination of both chemicals also efficiently reduced E. piscicida burden in the gill, intestine and head kidney of infected zebrafish (Danio rerio), and significantly improved their survival rate. Overall, these results suggested that the thioredoxin-mediated redox cascade is a potential target for novel antimicrobials, and that auranofin combined with colistin could be repurposed to effectively combat Edwardsiella infections.http://www.sciencedirect.com/science/article/pii/S2352513425002169Edwardsiella piscicidaAntibiotic resistanceAuranofinThioredoxin reductaseCombination therapy
spellingShingle Jinfang Lu
Yangbin Shi
Yajing Pan
Hans-Peter Grossart
Luyu Mei
Danli Xie
Wanchun Guan
He Zhang
Yongliang Lou
Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida
Aquaculture Reports
Edwardsiella piscicida
Antibiotic resistance
Auranofin
Thioredoxin reductase
Combination therapy
title Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida
title_full Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida
title_fullStr Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida
title_full_unstemmed Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida
title_short Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida
title_sort repurposing auranofin combined with colistin to effectively combat fish pathogenic edwardsiella piscicida
topic Edwardsiella piscicida
Antibiotic resistance
Auranofin
Thioredoxin reductase
Combination therapy
url http://www.sciencedirect.com/science/article/pii/S2352513425002169
work_keys_str_mv AT jinfanglu repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida
AT yangbinshi repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida
AT yajingpan repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida
AT hanspetergrossart repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida
AT luyumei repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida
AT danlixie repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida
AT wanchunguan repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida
AT hezhang repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida
AT yonglianglou repurposingauranofincombinedwithcolistintoeffectivelycombatfishpathogenicedwardsiellapiscicida